Congress Asset Management Co. increased its holdings in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 85.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,281,615 shares of the biopharmaceutical company's st